1. Home
  2. CVM vs GIFT Comparison

CVM vs GIFT Comparison

Compare CVM & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • GIFT
  • Stock Information
  • Founded
  • CVM 1983
  • GIFT 1999
  • Country
  • CVM United States
  • GIFT United States
  • Employees
  • CVM N/A
  • GIFT N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • GIFT Catalog/Specialty Distribution
  • Sector
  • CVM Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • CVM Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • CVM 40.1M
  • GIFT 37.1M
  • IPO Year
  • CVM 1987
  • GIFT N/A
  • Fundamental
  • Price
  • CVM $0.62
  • GIFT $1.21
  • Analyst Decision
  • CVM
  • GIFT
  • Analyst Count
  • CVM 0
  • GIFT 0
  • Target Price
  • CVM N/A
  • GIFT N/A
  • AVG Volume (30 Days)
  • CVM 469.2K
  • GIFT 27.3K
  • Earning Date
  • CVM 02-12-2025
  • GIFT 02-15-2025
  • Dividend Yield
  • CVM N/A
  • GIFT N/A
  • EPS Growth
  • CVM N/A
  • GIFT N/A
  • EPS
  • CVM N/A
  • GIFT N/A
  • Revenue
  • CVM N/A
  • GIFT $86,439,146.00
  • Revenue This Year
  • CVM N/A
  • GIFT N/A
  • Revenue Next Year
  • CVM $3,412.81
  • GIFT N/A
  • P/E Ratio
  • CVM N/A
  • GIFT N/A
  • Revenue Growth
  • CVM N/A
  • GIFT N/A
  • 52 Week Low
  • CVM $0.49
  • GIFT $0.50
  • 52 Week High
  • CVM $3.23
  • GIFT $4.65
  • Technical
  • Relative Strength Index (RSI)
  • CVM 45.83
  • GIFT N/A
  • Support Level
  • CVM $0.60
  • GIFT N/A
  • Resistance Level
  • CVM $0.78
  • GIFT N/A
  • Average True Range (ATR)
  • CVM 0.09
  • GIFT 0.00
  • MACD
  • CVM 0.02
  • GIFT 0.00
  • Stochastic Oscillator
  • CVM 45.66
  • GIFT 0.00

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: